本文選題：乳酸桿菌 + LGG�。� 參考：《浙江農(nóng)林大學(xué)》2015年碩士論文

【摘要】：益生菌廣泛用于調(diào)節(jié)動(dòng)物腸道健康,乳酸桿菌為應(yīng)用最早、研究最多的益生菌菌種之一。乳酸桿菌通過其不同成分能夠介導(dǎo)動(dòng)物胃腸道免疫調(diào)節(jié)作用,發(fā)揮益生效應(yīng),然而其免疫調(diào)節(jié)機(jī)制仍不明了。鑒于此,闡明乳酸桿菌具有怎么樣的腸道免疫調(diào)節(jié)功能,解析其免疫調(diào)節(jié)的信號(hào)通路及其關(guān)鍵靶點(diǎn),將為益生菌免疫調(diào)節(jié)功能的開發(fā)提供科學(xué)依據(jù),對(duì)篩選和培育高效乳酸桿菌等益生菌具有重要的實(shí)踐意義。本試驗(yàn)旨在以公認(rèn)的標(biāo)準(zhǔn)益生乳酸桿菌——鼠李糖乳酸桿菌(Lactobacillus rhamnosus GG,LGG)為代表,同時(shí)分離并獲得LGG不同成分(表面蛋白SLP、胞外多糖EPS、基因組DNA以及人工合成的未甲基化CpG ODN),分析LGG及其不同成分對(duì)人工致敏體外培養(yǎng)腸上皮細(xì)胞的免疫調(diào)節(jié)效應(yīng)和免疫保護(hù)作用,查明乳酸桿菌對(duì)小腸上皮細(xì)胞信號(hào)通路的調(diào)控作用,解析乳酸桿菌實(shí)現(xiàn)免疫調(diào)節(jié)作用的信號(hào)通路靶點(diǎn),闡明乳酸桿菌發(fā)揮腸道免疫調(diào)控作用的分子機(jī)制。與此同時(shí),以LGG作為參考菌株,構(gòu)建小鼠炎癥模型研究豬源乳酸桿菌(高粘附菌株Lactobacillus reuteri ZJ617和低粘附菌株Lactobacillus reuteri ZJ615)對(duì)腸道的免疫調(diào)節(jié)作用,分析乳酸桿菌介導(dǎo)動(dòng)物腸道免疫調(diào)節(jié)作用的機(jī)制。本研究主要采用大腸桿菌LPS分別誘導(dǎo)豬小腸上皮細(xì)胞系IPEC-J2細(xì)胞和C57BL/6小鼠產(chǎn)生免疫反應(yīng),構(gòu)建炎癥模型以評(píng)定乳酸桿菌的免疫調(diào)節(jié)作用。通過構(gòu)建豬小腸上皮細(xì)胞系IPEC-J2細(xì)胞脂多糖LPS炎癥模型,采用2×107 CFU/mL LGG或從LGG中分離純化獲得的不同成分(表面蛋白SLP、基因組DNA、胞外多糖EPS以及人工合成的未甲基化CpG ODN序列),分別預(yù)處理IPEC-J2細(xì)胞(1×106細(xì)胞/孔)4小時(shí),再以脂多糖LPS刺激細(xì)胞。同時(shí),通過構(gòu)建C57BL/6小鼠LPS炎癥模型,連續(xù)灌胃108 CFU/mL乳酸桿菌(LGG、ZJ617或ZJ615)一周后,腹腔注射LPS誘發(fā)炎癥。采用qRT-PCR技術(shù)檢測(cè)IPEC-J2細(xì)胞和小鼠腸道組織致炎性細(xì)胞因子以及Toll樣受體(TLR)的mRNA水平。采用Western-blot技術(shù)、免疫組化和免疫熒光技術(shù)分別檢測(cè)IPEC-J2細(xì)胞和小鼠腸道組織中炎癥相關(guān)信號(hào)通路(NF-κB信號(hào)通路和MAPK信號(hào)通路)主要靶點(diǎn)蛋白的表達(dá)水平。研究結(jié)果表明:1)與單純LPS刺激豬腸上皮IPEC-J2細(xì)胞相比,LGG預(yù)處理IPEC-J2細(xì)胞后顯著降低由LPS誘導(dǎo)的細(xì)胞致炎性細(xì)胞因子IL-6、IL-12、TNF-α和TLR受體TLR2、TLR4、TLR9的mRNA水平;細(xì)胞信號(hào)通路分子p38MAPK、ERK1/2和NF-κBp65的磷酸化水平顯著降低,而I-κBα表達(dá)量顯著上升(P0.05)。2)與單純LPS刺激IPEC-J2細(xì)胞相比,LGG表面蛋白SLP和胞外多糖EPS預(yù)處理IPEC-J2細(xì)胞后能夠顯著降低由LPS誘導(dǎo)的細(xì)胞致炎性細(xì)胞因子IL-6、IL-12、TNF-α和TLR受體TLR2、TLR4、TLR9的mRNA水平;細(xì)胞信號(hào)通路分子p38MAPK和NF-κBp65磷酸化水平顯著降低,而I-κBα表達(dá)量顯著上升(P0.05)。3)與單純LPS刺激IPEC-J2細(xì)胞相比,LGG未甲基化的CpG ODN預(yù)處理IPEC-J2細(xì)胞能夠顯著升高由LPS誘導(dǎo)的細(xì)胞致炎性細(xì)胞因子IL-6、IL-12、TNF-α水平和TLR受體TLR2、TLR4、TLR9的mRNA水平;信號(hào)通路分子p38MAPK、ERK1/2磷酸化水平與單純LPS刺激細(xì)胞相比沒有顯著差異(P0.05)。4)與單純LPS刺激未經(jīng)乳酸桿菌灌胃小鼠相比,LGG和低粘附力乳酸桿菌ZJ615連續(xù)灌胃一周的小鼠接受LPS刺激后,其腸道組織中炎性細(xì)胞因子IL-6、IL-12、TNF-α和TLR受體TLR2、TLR4、TLR9的mRNA水平顯著下降;腸道組織中信號(hào)通路分子p38MAPK、ERK1/2和NF-κBp65的磷酸化水平顯著降低,而I-κBα表達(dá)量顯著上升(P0.05)。5)與單純LPS刺激未經(jīng)乳酸桿菌灌胃小鼠相比,高粘附力乳酸桿菌ZJ617連續(xù)灌胃一周的小鼠接受LPS刺激后,其腸道組織中炎性細(xì)胞因子IL-6、IL-12、TNF-α和TLR受體TLR2、TLR4、TLR9的mRNA水平顯著升高,同時(shí)小鼠腸道組織中抗炎性細(xì)胞因子IL-10的mRNA水平顯著升高;腸道組織中信號(hào)通路分子I-κBα表達(dá)量顯著下降(P0.05)。研究結(jié)論:由此可見,鼠李糖乳酸桿菌LGG主要通過調(diào)節(jié)小腸上皮細(xì)胞Toll樣受體mRNA水平,抑制細(xì)胞MAPK和NF-κB信號(hào)通路激活,降低LPS誘導(dǎo)的炎性細(xì)胞因子mRNA水平,從而介導(dǎo)腸道免疫調(diào)節(jié)作用。鼠李糖乳酸桿菌LGG成分表面蛋白SLP、胞外多糖EPS以及未甲基化CpG ODN對(duì)LPS誘導(dǎo)的腸上皮細(xì)胞具有免疫調(diào)控作用,其中未甲基化CpG ODN具有免疫刺激作用。不同粘附力乳酸桿菌腸道免疫調(diào)節(jié)效應(yīng)存在差異,其中低粘附力乳酸桿菌ZJ615介導(dǎo)腸道免疫調(diào)控作用與LGG相似。
[Abstract]:Probiotics are widely used to regulate the intestinal health of animals. Lactobacillus is one of the earliest and most studied probiotic bacteria. Lactobacilli can mediate the immune regulation effect of animal gastrointestinal tract through its different components and play probiotic effect. However, the immune regulation mechanism is still unknown. The signal transduction pathway and the key target of the immunoregulation will provide a scientific basis for the development of the immunoregulation function of probiotics, and it is of great practical significance for the screening and breeding of probiotics such as the efficient Lactobacillus. This experiment aims at the recognized standard probiotic Lactobacillus, Lactobacillus Rhamnus (Lactob). Acillus rhamnosus GG, LGG) as the representative, at the same time separate and obtain the different components of LGG (surface protein SLP, extracellular polysaccharide EPS, genomic DNA, and synthetic CpG ODN), analyze the immunological and immune protective effects of LGG and its different components on the cultured intestinal epithelial cells in vitro, and identify the lactobacillus to the small intestine. The regulatory role of epithelial cell signaling pathway, the signal pathway target of Lactobacillus to realize immunoregulation, and the molecular mechanism of lactobacilli to play the role of intestinal immune regulation. At the same time, LGG is used as a reference strain to construct a mouse model of lactobacilli (high adhesion strain Lactobacillus reuteri ZJ617). The immunoregulation effect of low adhesion strain Lactobacillus reuteri ZJ615 on intestinal tract was analyzed. The mechanism of lactic acid bacilli mediated intestinal immunoregulation in animals was analyzed. This study mainly used Escherichia coli LPS to induce the immune response of IPEC-J2 and C57BL/6 mice in small intestinal epithelial cell lines, and to construct an inflammatory model to assess the lactic acid lever. By constructing the inflammatory model of lipopolysaccharide LPS in the IPEC-J2 cell line of the pig small intestinal epithelial cell line, the different components (surface protein SLP, genomic DNA, extracellular polysaccharide EPS, and synthetic CpG ODN sequence) were obtained by constructing the inflammatory model of lipopolysaccharide in the IPEC-J2 cell line of the pig small intestinal epithelial cell line (1 * 106 fines, respectively, for the sequence of the surface protein SLP, the genomic DNA, the extracellular polysaccharide EPS and the synthetic CpG ODN sequence). At the same time, the cells were stimulated by lipopolysaccharide LPS for 4 hours. At the same time, the inflammation was induced by intraperitoneal injection of LPS (LGG, ZJ617 or ZJ615) by intraperitoneal injection of 108 CFU/mL Lactobacillus (LGG, ZJ617 or ZJ615) for a week after construction of LPS inflammation model in the mice. The qRT-PCR technique was used to detect inflammatory cytokines and Toll like receptors (TLR) in IPEC-J2 cells and mice intestinal tissues. Level. Western-blot technique, immunohistochemistry and immunofluorescence technique were used to detect the expression level of major target proteins in IPEC-J2 cells and mouse intestinal tissues (NF- kappa B signaling pathway and MAPK signaling pathway). The results showed that: 1) LGG pretreated IPEC- compared with pure LPS stimulation of pig intestinal epithelial IPEC-J2 cells. J2 cells significantly reduced the LPS induced inflammatory cell factor IL-6, IL-12, TNF- alpha and TLR receptor TLR2, TLR4, TLR9 mRNA level, cell signaling molecule p38MAPK, ERK1/2 and nuclear kappa phosphorylation level significantly decreased. P and extracellular polysaccharide EPS pretreated IPEC-J2 cells can significantly reduce the LPS induced inflammatory cell factor IL-6, IL-12, TNF- alpha and TLR receptor TLR2, TLR4, TLR9 mRNA levels; Compared with the cells, the CpG ODN pretreated by LGG without methylated IPEC-J2 cells could significantly increase the LPS induced inflammatory cell factor IL-6, IL-12, TNF- alpha and TLR receptor TLR2, TLR4, TLR9. S stimulated the mice with LGG and low adhesion Lactobacillus ZJ615 for one week after the stimulation of LPS stimulation, and the inflammatory cytokine IL-6, IL-12, TNF- A and TLR receptor TLR2, TLR4, TLR9 mRNA levels in the intestinal tissue decreased significantly. The expression of I- kappa B alpha significantly increased (P0.05).5). Compared with the simple LPS stimulation of the mice without Lactobacillus irrigated the mice, the mice with high adhesion Lactobacillus ZJ617 received LPS stimulation for one week, and the inflammatory cytokines IL-6, IL-12, TNF- A and TLR receptor TLR2 in the intestinal tissue were significantly increased. At the same time, the mRNA level of anti inflammatory cytokine IL-10 in the intestinal tissue of mice was significantly increased, and the expression of I- kappa B alpha in the intestinal tissue was significantly decreased (P0.05). Conclusion: this can be seen from this conclusion: this can be seen that the Lactobacillus rhamnose LGG mainly inhibits MAPK and NF- kappa B signaling pathway by regulating the Toll like mRNA level in small intestinal epithelial cells. Live, reduce the level of inflammatory cytokine mRNA induced by LPS, and mediate intestinal immunoregulation. The surface protein SLP of Lactobacillus rhamnolipid LGG, extracellular polysaccharide EPS and CpG ODN have immune regulation effect on LPS induced intestinal epithelial cells, in which the non methylation CpG ODN has the immune stimulation effect. Different adhesion milk The intestinal mucosal immunoregulatory effects of acid bacilli were different. Among them, the low adhesion force Lactobacillus ZJ615 mediated intestinal immune regulation was similar to that of LGG.
【學(xué)位授予單位】：浙江農(nóng)林大學(xué)
【學(xué)位級(jí)別】：碩士
【學(xué)位授予年份】：2015
【分類號(hào)】：S816

【相似文獻(xiàn)】

相關(guān)期刊論文 前10條

1 曾慷,何建國(guó),王曉紅,翁少萍,左濤;傳染性脾腎壞死病毒、ConA和LPS對(duì)體外鱖的頭腎淋巴細(xì)胞轉(zhuǎn)化的影響[J];水產(chǎn)學(xué)報(bào);2001年05期

2 王林楓;楊國(guó)宇;王月影;朱河水;韓立強(qiáng);張震;楊改青;;LPS急性肝損傷對(duì)奶山羊肝臟營(yíng)養(yǎng)代謝的影響[J];畜牧與獸醫(yī);2012年S1期

3 劉為民,武楓林,毛鑫智;靜脈灌注LPS對(duì)山羊血漿一氧化氮水平的影響[J];畜牧與獸醫(yī);2002年07期

4 段慧琴,喬健,張永東,索占偉,穆祥,許劍琴;LPS對(duì)大鼠腸黏膜微血管內(nèi)皮細(xì)胞分泌NO的影響[J];畜牧獸醫(yī)學(xué)報(bào);2005年09期

5 江青東;汪新建;楊國(guó)宇;王艷玲;王月影;查光明;朱河水;劉鳳娟;;LPS調(diào)節(jié)奶牛肝細(xì)胞脂代謝相關(guān)基因的表達(dá)[J];畜牧與獸醫(yī);2012年S1期

6 郭凡溪;劉騰飛;耿智霞;蔣凡;余祖功;;復(fù)方甘草酸單銨可溶性粉對(duì)恩諾沙星聯(lián)合LPS致雞肝損傷保護(hù)機(jī)制研究[J];南京農(nóng)業(yè)大學(xué)學(xué)報(bào);2013年02期

7 齊仁立;解蕓菲;孫嬋;王勇;孫超;;大腸埃希菌LPS感染對(duì)烏雞脂肪代謝及相關(guān)調(diào)控基因表達(dá)的影響[J];西北農(nóng)林科技大學(xué)學(xué)報(bào)(自然科學(xué)版);2011年08期

8 胡火庚;汪成竹;陳昌福;;三種致病菌粗脂多糖(LPS)對(duì)團(tuán)頭魴的免疫原性[J];飼料工業(yè);2010年08期

9 李培鋒;李成應(yīng);希日莫;關(guān)紅;李利平;;秦公散對(duì)LPS活化的內(nèi)皮細(xì)胞表達(dá)黏附分子和分泌一氧化氮的影響[J];動(dòng)物醫(yī)學(xué)進(jìn)展;2010年11期

10 ;LPS牛奶保鮮劑[J];中國(guó)農(nóng)墾;1995年08期

相關(guān)會(huì)議論文 前10條

1 張卓超;李霄;馬奔;紀(jì)洪辰;陶開山;竇科峰;;LPS預(yù)處理的骨髓間充質(zhì)干細(xì)胞對(duì)移植后胰島的保護(hù)作用的研究[A];2013中國(guó)器官移植大會(huì)論文匯編[C];2013年

2 何文喜;Cooper PR;Anthony J.Smith;;LPS對(duì)牙本質(zhì)涎磷蛋白基因表達(dá)調(diào)控的研究[A];全國(guó)第三次牙體牙髓病學(xué)臨床技術(shù)研討會(huì)論文匯編[C];2009年

3 廖爽;王玉蕾;曹一鳴;;數(shù)學(xué)課堂中師生對(duì)話研究——基于LPS項(xiàng)目課堂錄像資料[A];全國(guó)高等師范院校數(shù)學(xué)教育研究會(huì)2008年學(xué)術(shù)年會(huì)論文集[C];2008年

4 曾悅翔;徐道妙;;利多卡因預(yù)處理對(duì)LPS誘導(dǎo)的肺泡Ⅱ型上皮細(xì)胞水通道蛋白5的影響[A];中華醫(yī)學(xué)會(huì)第五次全國(guó)重癥醫(yī)學(xué)大會(huì)論文匯編[C];2011年

5 王金生;龍菊英;張桂英;潘小枚;楊悅;;水稻黃單胞LPS合成基因簇的鑒定及功能分析[A];中國(guó)植物病理學(xué)會(huì)2005年學(xué)術(shù)年會(huì)暨植物病理學(xué)報(bào)創(chuàng)刊50周年紀(jì)念會(huì)論文摘要集[C];2005年

6 王金生;龍菊英;張桂英;潘小枚;楊悅;;水稻黃單胞LPS合成基因簇的鑒定及功能分析[A];中國(guó)植物病理學(xué)會(huì)2005年學(xué)術(shù)年會(huì)暨植物病理學(xué)報(bào)創(chuàng)刊50周年紀(jì)念會(huì)論文集[C];2005年

7 王林楓;楊國(guó)宇;王月影;朱河水;韓立強(qiáng);張震;楊改青;;LPS急性肝損傷對(duì)奶山羊肝臟營(yíng)養(yǎng)代謝的影響[A];全國(guó)動(dòng)物生理生化第十二次學(xué)術(shù)交流會(huì)論文摘要匯編[C];2012年

8 周捷;;脆弱類桿菌脂多糖(LPS)對(duì)正常人外周血單個(gè)核細(xì)胞分泌IL-10及凋亡的影響[A];全國(guó)危重?zé)齻颊咴缙趶?fù)蘇對(duì)策專題研討會(huì)論文匯編[C];2005年

9 周捷;黃曉元;;脆弱類桿菌脂多糖(LPS)對(duì)正常人外周血單個(gè)核細(xì)胞分泌IL-10及凋亡的影響[A];第四屆全國(guó)燒傷救治專題研討會(huì)燒傷感染救治新進(jìn)展論文匯編[C];2006年

10 江青東;汪新建;楊國(guó)宇;王艷玲;王月影;查光明;朱河水;劉鳳娟;;LPS調(diào)節(jié)奶牛肝細(xì)胞脂代謝相關(guān)基因的表達(dá)[A];全國(guó)動(dòng)物生理生化第十二次學(xué)術(shù)交流會(huì)論文摘要匯編[C];2012年

相關(guān)博士學(xué)位論文 前10條

1 郭建紅;多次小劑量LPS處理減輕慢性肝損傷的機(jī)制研究[D];山西醫(yī)科大學(xué);2010年

2 趙素賢;原發(fā)性膽汁性肝硬化（PBC）臨床病理特點(diǎn)及LPS在其發(fā)病中作用的研究[D];中國(guó)人民解放軍軍事醫(yī)學(xué)科學(xué)院;2008年

3 趙延濤;LPS致流產(chǎn)作用及保胎中藥的調(diào)控效應(yīng)研究[D];河北農(nóng)業(yè)大學(xué);2011年

4 邢金燕;辛伐他汀對(duì)LPS誘導(dǎo)內(nèi)皮祖細(xì)胞功能的影響[D];山東大學(xué);2011年

5 鄭山根;LPS多表位模擬肽及抗原性的研究[D];中國(guó)人民解放軍第一軍醫(yī)大學(xué);2003年

6 金鵬鋒;益生菌對(duì)LPS誘導(dǎo)的小鼠肝損傷和炎癥因子表達(dá)的影響作用及機(jī)制研究[D];浙江大學(xué);2015年

7 凌燕;肝素抑制HMGB1放大LPS炎癥效應(yīng)的作用及機(jī)制研究[D];華中科技大學(xué);2011年

8 劉偉;腎上腺髓質(zhì)素對(duì)LPS抑制人臍靜脈內(nèi)皮細(xì)胞TFPI基因表達(dá)的影響及其分子機(jī)制[D];中國(guó)協(xié)和醫(yī)科大學(xué);2007年

9 孫學(xué)剛;LPS受體介導(dǎo)的細(xì)胞激活的信號(hào)機(jī)制研究[D];中國(guó)人民解放軍第一軍醫(yī)大學(xué);2003年

10 王樂怡;LPS預(yù)處理誘導(dǎo)的基質(zhì)細(xì)胞再編程調(diào)控角膜抗真菌天然免疫的分子機(jī)制[D];山東大學(xué);2014年

，

本文編號(hào)：2057600